These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5415502)

  • 21. [Fluorescence and cytological diagnosis of measles].
    Nosková J; Novák A
    Zentralbl Bakteriol Orig; 1971; 216(2):158-61. PubMed ID: 4928072
    [No Abstract]   [Full Text] [Related]  

  • 22. [Findings on immunoprophylaxis of measles in the light of its present clinical aspects].
    Mussa GC; Pavesio D; Ballario R
    Minerva Pediatr; 1967 Sep; 19(37):1702-7. PubMed ID: 5616764
    [No Abstract]   [Full Text] [Related]  

  • 23. Large outbreak of measles in a community with high vaccination coverage: implications for the vaccination schedule.
    Domínguez A; Torner N; Barrabeig I; Rovira A; Rius C; Cayla J; Plasencia E; Minguell S; Sala MR; Martínez A; Costa J; Mosquera M; Cabezas C;
    Clin Infect Dis; 2008 Nov; 47(9):1143-9. PubMed ID: 18823269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Seroconversion following vaccination with a new measles vaccine strain].
    Just M; Wegmann A
    Ther Umsch; 1983 Mar; 40(3):261-3. PubMed ID: 6857567
    [No Abstract]   [Full Text] [Related]  

  • 26. Laboratory testing and confirmation of suspected measles infection crucial in countries that have eliminated measles.
    Riddell MA; Kelly HA; Featherstone D; Rota P
    Ann Emerg Med; 2009 Oct; 54(4):639-40; author reply 640. PubMed ID: 19769897
    [No Abstract]   [Full Text] [Related]  

  • 27. Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(28):603-6. PubMed ID: 8676852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 29. A rash of exanthems. How they affect children and pregnant women.
    Starr M
    Aust Fam Physician; 2000 Jul; 29(7):631-3, 636-7. PubMed ID: 10914446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measles during pregnancy including neonates.
    Arya SC; Agarwal N
    J Infect; 2005 Nov; 51(4):340-1. PubMed ID: 16291291
    [No Abstract]   [Full Text] [Related]  

  • 31. PAHO measles reference laboratory network.
    Bull Pan Am Health Organ; 1995 Sep; 29(3):276-8. PubMed ID: 8520613
    [No Abstract]   [Full Text] [Related]  

  • 32. [Atypical measles pneumonia in a young adult female].
    Araya Y; Miyamoto K; Suzuki J; Abe S; Kawakami Y; Ogasawara K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1984 Oct; 22(10):920-4. PubMed ID: 6530859
    [No Abstract]   [Full Text] [Related]  

  • 33. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Laboratory surveillance of measles. Chile, 1992-1995].
    Vicente M; Yung V; Fasce R; Lezano V; Vera L; Villagra E; Espiñeira E
    Rev Med Chil; 1998 Jan; 126(1):107-14. PubMed ID: 9629761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimum age of measles immunization--maternal and transplacentally transmitted measles antibodies in infancy.
    Mohan M; Mehta PK; Sehgal S; Prabhakar AK; Bhargava SK
    Indian Pediatr; 1981 Sep; 18(9):631-5. PubMed ID: 7319611
    [No Abstract]   [Full Text] [Related]  

  • 36. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 37. Measles epidemiology and its implications for a vaccination programme in Oman.
    Patel PK; Al-Awaidy ST; Bawikar S; Al-Busaidy S; Al-Mahrooqi S
    East Mediterr Health J; 2008; 14(3):579-89. PubMed ID: 18720622
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seroepidemiological study of measles after the 1992 nationwide MMR revaccination program in Taiwan.
    Chiu HH; Lee CY; Chih TW; Lee PI; Chang LY; Lin YJ; Hsu CM; Huang LM
    J Med Virol; 1997 Jan; 51(1):32-5. PubMed ID: 8986946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Waning immunity and subclinical measles infections in England.
    Glass K; Grenfell BT
    Vaccine; 2004 Sep; 22(29-30):4110-6. PubMed ID: 15364464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.